Rezvan Najafi (R Najafi)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 33

Top Topics

Signaling Pathway

Top Venues

Molecular biology reports

Journal of gastrointestinal cancer

Oxidative medicine and cellular longevity

Journal of cellular physiology

This page only lists publications with an associated author ORCID identifier.

Publications

Razieh Amini, Shadi Moradi, Rezvan Najafi, Mehrdokht Mazdeh, Amir Taherkhani
BACE1 Inhibition Utilizing Organic Compounds Holds Promise as a Potential Treatment for Alzheimer's and Parkinson's Diseases. Oxidative medicine and cellular longevity 2024 (2024)
Razieh Amini, Shadi Moradi, Rezvan Najafi, Mehrdokht Mazdeh, Amir Taherkhani
BACE1 Inhibition Utilizing Organic Compounds Holds Promise as a Potential Treatment for Alzheimer's and Parkinson's Diseases. Oxidative medicine and cellular longevity 2024 (2024)
Razieh Amini, Shadi Moradi, Rezvan Najafi, Mehrdokht Mazdeh, Amir Taherkhani
BACE1 Inhibition Utilizing Organic Compounds Holds Promise as a Potential Treatment for Alzheimer's and Parkinson's Diseases. Oxidative medicine and cellular longevity 2024 (2024)
Hamed Karkehabadi, Roshanak Abbasi, Rezvan Najafi, Elham Khoshbin
The effects of melatonin on the viability and osteogenic/odontogenic differentiation of human stem cells from the apical papilla. Molecular biology reports (2023)
Mina Eslami, Farid Azizi Jalilian, Rezvan Najafi, Ali Mahdavinezhad, Razieh Amini
Promising Modulatory Effects of Cenicriviroc on the Progression of Mouse Colorectal Cancer through Inhibition of CCR2_CCL2 Signaling Pathway. Evidence-based complementary and alternative medicine : eCAM 2023 (2023)
Zahra Azarifar, Razieh Amini, Hamid Tanzadehpanah, Saeid Afshar, Rezvan Najafi
In vitro co-delivery of 5-fluorouracil and all-trans retinoic acid by PEGylated liposomes for colorectal cancer treatment. Molecular biology reports (2023)
Sima Nobari, Rezvan Najafi, Ali Mahdavinezhad, Akram Jalali, Razieh Amini
The Combination of Zerumbone with 5-Fluorouracil for Sensitizing Colorectal Cancer-Associated Fibroblasts to Treatment. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Hamed Karkehabadi, Erfan Ahmadyani, Rezvan Najafi, Elham Khoshbin
Effect of biodentine coated with emdogain on proliferation and differentiation of human stem cells from the apical papilla. Molecular biology reports 49 (5) (2022)
Bahram Yavari, Seyyed Shamsadin Athari, Yadollah Omidi, Akram Jalali, Rezvan Najafi
EpCAM aptamer activated 5-FU-loaded PLGA nanoparticles in CRC treatment; in vitro and in vivo study. Journal of drug targeting (2022)
Nashmin Fayazi Hosseini, Razieh Dalirfardouei, Mohammad Reza Aliramaei, Rezvan Najafi
Stem cells or their exosomes: which is preferred in COVID-19 treatment? Biotechnology letters 44 (2) (2022)
Nooshin Abbasi, Rezvan Najafi
Cupping Therapy as an Anti-inflammation Therapy and Immunomodulator in Cancer Patients. Journal of gastrointestinal cancer (2021)
Nashmin Fayazi, Mohsen Sheykhhasan, Sara Soleimani Asl, Rezvan Najafi
Stem Cell-Derived Exosomes: a New Strategy of Neurodegenerative Disease Treatment. Molecular neurobiology 58 (7) (2021)
Mahsa Rezaeepoor, Golnaz Rashidi, Mona Pourjafar, Chiman Mohammadi, Ghasem Solgi, Rezvan Najafi
SEMA4D Knockdown Attenuates β-Catenin-Dependent Tumor Progression in Colorectal Cancer. BioMed research international 2021 (2021)
Fatemeh Bahreini, Massoud Saidijam, Zahra Mousivand, Rezvan Najafi, Saeid Afshar
Assessment of lncRNA DANCR, miR-145-5p and NRAS axis as biomarkers for the diagnosis of colorectal cancer. Molecular biology reports 48 (4) (2021)
Chiman Mohammadi, Rezvan Najafi
DCLK1 as a Promising Marker for Radioresistance in Colorectal Cancer. Journal of gastrointestinal cancer 51 (2) (2021)
Saeideh Gholamzadeh Khoei, Massoud Saidijam, Razieh Amini, Akram Jalali, Rezvan Najafi
Impact of PIN1 Inhibition on Tumor Progression and Chemotherapy Sensitivity in Colorectal Cancer. Journal of gastrointestinal cancer (2021)
Fariba Pishbin, Nasrin Ziamajidi, Roghayeh Abbasalipourkabir, Rezvan Najafi, Maryam Farhadian
Correlation of miR-600 with WT1 expression and its potential clinical significance in breast cancer. Personalized medicine 18 (1) (2021)
Razieh Dehghan, Rezvan Najafi, Farid Azizi Jalilian, Massoud Saidijam, Zahra Radaei, Alireza Zamani, Razieh Ezati, Farzaneh Asna-Ashari, Razieh Amini
A promising effect of zerumbone with improved anti-tumor-promoting inflammation activity of miR-34a in colorectal cancer cell lines. Molecular biology reports 48 (1) (2021)
Golnaz Rashidi, Mahsa Rezaeepoor, Chiman Mohammadi, Ghasem Solgi, Rezvan Najafi
Inhibition of semaphorin 4D enhances chemosensitivity by increasing 5-fluorouracile-induced apoptosis in colorectal cancer cells. Molecular biology reports 47 (9) (2020)
Saeideh Gholamzadeh Khoei, Nashmin Fayazi, Rezvan Najafi
Sphingosine kinase 1 could enhance stem cell therapy efficiency for neurodegenerative diseases through induction of HIF-1. The International journal of neuroscience 131 (1) (2020)
Saba Sameri, Massoud Saidijam, Fatemeh Bahreini, Rezvan Najafi
Cancer Chemopreventive Activities of Silibinin on Colorectal Cancer through Regulation of E-Cadherin/β-Catenin Pathway. Nutrition and cancer 73 (8) (2020)
Tayebe Artimani, Rezvan Najafi
APPL1 as an important regulator of insulin and adiponectin-signaling pathways in the PCOS: A narrative review. Cell biology international 44 (8) (2020)
Mona Pourjafar, Pouria Samadi, Manoochehr Karami, Rezvan Najafi
Assessment of clinicopathological and prognostic relevance of BMI-1 in patients with colorectal cancer: A meta-analysis. Biotechnology and applied biochemistry (2020)
Fatemeh Karimi Dermani, Rezvan Najafi
miR-200c as a Predictive Biomarker for 5-Fluorouracil Chemosensitivity in Colorectal Cancer. Journal of gastrointestinal cancer 49 (1) (2019)
Narges Hosseini, Amineh Khoshnazar, Massoud Saidijam, Farid Azizi Jalilian, Rezvan Najafi, Ali Mahdavinezhad, Razie Ezati, Ali Reza Soltanian, Razieh Amini
Zerumbone Suppresses Human Colorectal Cancer Invasion and Metastasis via Modulation of FAk/PI3k/NFκB-uPA Pathway. Nutrition and cancer 71 (1) (2019)
S G Khoei, C Mohammadi, Y Mohammadi, S Sameri, Rezvan Najafi
Prognostic value of peptidyl-prolyl cis-trans isomerase 1 (PIN1) in human malignant tumors. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 22 (7) (2019)
Fatemeh Karimi Dermani, Razieh Amini, Massoud Saidijam, Mona Pourjafar, Sahar Saki, Rezvan Najafi
Zerumbone inhibits epithelial-mesenchymal transition and cancer stem cells properties by inhibiting the β-catenin pathway through miR-200c. Journal of cellular physiology 233 (12) (2018)
Fateme Karimi Dermani, Razieh Amini, Massoud Saidijam, Rezvan Najafi
miR-200c, a tumor suppressor that modulate the expression of cancer stem cells markers and epithelial-mesenchymal transition in colorectal cancer. Journal of cellular biochemistry 119 (7) (2018)
Mitra Karimi Mazraehshah, Seyed Mohammad Tavangar, Massoud Saidijam, Razieh Amini, Fatemeh Bahreini, Fatemeh Karimi Dermani, Rezvan Najafi
Anticancer effects of miR-200c in colorectal cancer through BMI1. Journal of cellular biochemistry 119 (12) (2018)
Pouria Samadi, Saeid Afshar, Razieh Amini, Rezvan Najafi, Ali Mahdavinezhad, Abdolazim Sedighi Pashaki, Mohammad Hadi Gholami, Massoud Saidijam
Let-7e enhances the radiosensitivity of colorectal cancer cells by directly targeting insulin-like growth factor 1 receptor. Journal of cellular physiology 234 (7) (2018)
Hadi Bamehr, Massoud Saidijam, Dara Dastan, Razieh Amini, Mona Pourjafar, Rezvan Najafi
Ferula pseudalliacea induces apoptosis in human colorectal cancer HCT-116 cells via mitochondria-dependent pathway. Archives of physiology and biochemistry 125 (3) (2018)
Fatemeh K Dermani, Pouria Samadi, Golebagh Rahmani, Alisa K Kohlan, Rezvan Najafi
PD-1/PD-L1 immune checkpoint: Potential target for cancer therapy. Journal of cellular physiology 234 (2) (2018)
Saman Seyedabadi, Massoud Saidijam, Rezvan Najafi, Seyed Habibollah Mousavibahar, Mohammad Jafari, Sajjad MohammadGanji, Ali Mahdavinezhad
Assessment of CEP55, PLK1 and FOXM1 expression in patients with bladder cancer in comparison with healthy individuals. Cancer investigation 36 (8) (2018)